Photo by finnnyc from unsplash
Despite a high approval rate, there were unnecessary delays in therapy due to prior authorizations. This study identified the impact of type of IBD, FDA-labeled indication, and dose escalations on… Click to show full abstract
Despite a high approval rate, there were unnecessary delays in therapy due to prior authorizations. This study identified the impact of type of IBD, FDA-labeled indication, and dose escalations on approvals.
Keywords:
therapy associated;
delays therapy;
inflammatory bowel;
current prior;
associated current
Journal Title: Inflammatory bowel diseases
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Inflammatory bowel diseases
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!